Shirley V Hodgson
Overview
Explore the profile of Shirley V Hodgson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
2804
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Foulkes W, Hodgson S, Maher E, Ngeow J, Reardon W, Trembath R
J Med Genet
. 2024 Dec;
62(1):46-47.
PMID: 39740808
No abstract available.
2.
Andreou A, Yngvadottir B, Bassaganyas L, Clark G, Martin E, Whitworth J, et al.
Hum Mol Genet
. 2022 Mar;
31(16):2728-2737.
PMID: 35323939
Around 95% of patients with clinical features that meet the diagnostic criteria for von Hippel-Lindau disease (VHL) have a detectable inactivating germline variant in VHL. The VHL protein (pVHL) functions...
3.
Andrews K, Ascher D, Pires D, Barnes D, Vialard L, Casey R, et al.
J Med Genet
. 2018 Feb;
55(6):384-394.
PMID: 29386252
Background: Germline pathogenic variants in / are the most frequent causes of inherited phaeochromocytomas/paragangliomas. Insufficient information regarding penetrance and phenotypic variability hinders optimum management of mutation carriers. We estimate penetrance...
4.
Smith S, Sirohi D, Ohe C, McHugh J, Hornick J, Kalariya J, et al.
Histopathology
. 2017 Feb;
71(1):42-52.
PMID: 28165631
Aims: Fumarate hydratase (FH)-deficient renal cell carcinoma (RCC) is a high-grade, aggressive tubulopapillary carcinoma, arising predominantly in the setting of the hereditary leiomyomatosis-RCC syndrome of familial uterocutaneous leiomyomatosis and deficiency...
5.
Painter J, OMara T, Marquart L, Webb P, Attia J, Medland S, et al.
Cancer Epidemiol Biomarkers Prev
. 2016 Aug;
25(11):1503-1510.
PMID: 27550749
Background: The strongest known risk factor for endometrial cancer is obesity. To determine whether SNPs associated with increased body mass index (BMI) or waist-hip ratio (WHR) are associated with endometrial...
6.
Movahedi M, Bishop D, Macrae F, Mecklin J, Moeslein G, Olschwang S, et al.
J Clin Oncol
. 2015 Aug;
33(31):3591-7.
PMID: 26282643
Purpose: In the general population, increased adiposity is a significant risk factor for colorectal cancer (CRC), but whether obesity has similar effects in those with hereditary CRC is uncertain. This...
7.
Peterlongo P, Chang-Claude J, Moysich K, Rudolph A, Schmutzler R, Simard J, et al.
Cancer Epidemiol Biomarkers Prev
. 2014 Oct;
24(1):308-16.
PMID: 25336561
Background: BRCA1 and BRCA2 mutation carriers are at substantially increased risk for developing breast and ovarian cancer. The incomplete penetrance coupled with the variable age at diagnosis in carriers of...
8.
Rogers A, Nesbit M, Hannan F, Howles S, Gorvin C, Cranston T, et al.
J Clin Endocrinol Metab
. 2014 Apr;
99(7):E1300-5.
PMID: 24708097
Context: Autosomal dominant hypocalcemia (ADH) types 1 and 2 are due to calcium-sensing receptor (CASR) and G-protein subunit-α11 (GNA11) gain-of-function mutations, respectively, whereas CASR and GNA11 loss-of-function mutations result in...
9.
Nieuwenhuis M, Kets C, Murphy-Ryan M, Yntema H, Evans D, Colas C, et al.
Fam Cancer
. 2013 Aug;
13(1):57-63.
PMID: 23934601
Patients with germline PTEN mutations are at high risk of developing benign and malignant tumours. We aimed to evaluate the cumulative risk of several types of cancer and of dysplastic...
10.
van El C, Cornel M, Borry P, Hastings R, Fellmann F, Hodgson S, et al.
Eur J Hum Genet
. 2013 Jul;
21 Suppl 1:S1-5.
PMID: 23819146
No abstract available.